Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sniper007on Sep 15, 2020 6:41pm
272 Views
Post# 31564461

RE:RE:This should work

RE:RE:This should work

A couple of shareholders have previously indicated that they would sell their stock for $3-5 but this is exactly why bioasis is worth multiples of $10.

3.7 billion for 30% and 12.4 billion for the whole sha-bang? and we're at $0.40. Can't wait for this thing to explode.

That said, it looks like we're in this for at least another year, but as stated, this technology is potentially worth multiple billions of dollars so don't sell yourself short (your shares!) for any low-ball offers that may come along for short term gains... and my opinion is that offers will come, maybe even in the next year. Be patient and let this play out - don't let any potential low ball offers sway you!

Remember, xb3-001 is only 1 drug out of roughly 200 that we could likely get into the brain (x-CEO Rob Hutchison indicated that a number of years ago). Numbers get stupid when you think about it. Hold on people.

It annoys me when I hear people saying they would sell their shares for dirt.

Sniper

Bullboard Posts